Teva, Baxter Hit With $500M Damages In Hepatitis Case
U.S. subsidiaries of Teva Pharmaceuticals Industries Ltd. and Baxter International Inc. reportedly have been hit with a $500 million punitive damages award in the first suit among hundreds to go to...To view the full article, register now.
Already a subscriber? Click here to view full article